7 results on '"Le Pennec, P.-Y."'
Search Results
2. Les phénotypes érythrocytaires rares : un enjeu de santé publique
- Author
-
Peyrard, T., Pham, B.-N., Le Pennec, P.-Y., and Rouger, P.
- Subjects
- *
BLOOD groups , *ANTIGENS , *PHENOTYPES , *IMMUNOGLOBULINS - Abstract
Abstract: A rare blood group is usually defined as the absence of a high prevalence antigen or the absence of several antigens within a single blood group system, if its prevalence in France is 4/1000 or less in the general population. An individual with a rare blood phenotype can develop a naturally-occurring or immune antibody corresponding to his rare specificity. In case an extremely low stock of compatible blood is available at the national level, a so-called “transfusion deadlock” is described. Most of the individuals with a rare blood group are coincidently identified when a routine pretransfusion testing or pregnancy follow-up is performed, if the antibody(ies) corresponding to the rare specificity is(are) present. Other individuals are discovered following a systematic red cell typing, or family investigations in siblings. One hundred and twenty-one rare blood specificities and 42 rare blood genotypes are currently defined at the French National Reference Laboratory for Blood Groups (CNRGS–Paris). The French national registry of individuals with a rare blood phenotype/genotype includes about 9600 people, who are urged to regularly donate blood for the National Rare Blood Bank. This bank, based on a homologous blood transfusion program, is in charge of the long-term storage of rare frozen blood units, that can only be delivered after receiving authorization from the CNRGS. The global and individual care management of the individuals with a rare blood group, concerning potentially several hundred thousand people in France, requires a close cooperation between all the protagonists within the transfusion chain. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
3. FY*X real-time polymerase chain reaction with melting curve analysis associated with a complete one-step real-time FY genotyping.
- Author
-
Ansart-Pirenne, H., Martin-Blanc, S., Le Pennec, P.-Y., Rouger, P., Cartron, J.-P., and Tournamille, C.
- Subjects
- *
POLYMERASE chain reaction , *DUFFY blood group system , *GENETICS , *ANTIGENS , *PHENOTYPES , *ADSORPTION (Chemistry) - Abstract
Background and Objectives The Duffy ( FY) blood group system is controlled by four major alleles: FY*A and FY*B, the Caucasian common alleles, encoding Fya and Fyb antigens; FY*X allele responsible for a poorly expressed Fyb antigen, and FY*Fy a silent predominant allele among Black population. Despite the recent development of a real-time fluorescent polymerase chain reaction (PCR) method for FY genotyping FY*X genotyping has not been described by this method. This study focused on the real-time FY*X genotyping development associated with a complete, one-step real-time FY genotyping, based on fluorescence resonance energy transfer (FRET) technology. Materials and Methods Seventy-two blood samples from Fy(a+b–) Caucasian blood donors were studied by real-time PCR only. Forty-seven Caucasian and Black individual blood samples, referred to our laboratory, were studied by PCR-RFLP and real-time PCR. For each individual, the result of the genotype was compared to the known phenotype. Results The FY*X allele frequency calculated in an Fy(a+b–) Caucasian blood donors population was 0·014. With the Caucasian and Black patient samples we found a complete correlation between PCR-RFLP and the real-time PCR method whatever the alleles combination tested. When the known phenotype was not correlated to FY*X genotype, the presence of the Fyb antigen was always confirmed by adsorption–elution. Conclusion The real-time technology method is rapid and accurate for FY genotyping. From now, we are able to detect the FY*X allele in all the alleles combinations studied. Regarding its significant frequency, the detection of the FY*X allele is useful for the correct typing of blood donors and recipients considering the therapeutic use of blood units and the preparation of test red blood cells for antibody screening. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
4. Génotypage des systèmes de groupe sanguin d’intérêt transfusionnel au CNRGS. I : les systèmes FY, JK, MNS
- Author
-
Pham, B.N., Peyrard, T., Ripaux, M., Bourgouin, S., Martin-Blanc, S., Le Pennec, P.-Y., and Rouger, P.
- Subjects
- *
BLOOD group antigens , *BLOOD transfusion , *MNSS blood group system , *IMMUNOHEMATOLOGY , *MOLECULAR genetics , *PHENOTYPES - Abstract
Abstract: Aim of the study: Determination of blood group antigens from data obtained by using molecular methods (genotyping) has become an indispensable tool in the specialized immunohematology laboratories. The French National Reference Centre for Blood group typing (CNRGS) routinely performs genotyping of the FY, JK and MNS system (common genotyping), providing a phenotype deduced from genotyping data for FY1, FY2, JK1, JK2, MNS3 and MNS4 antigens. Patients and methods: We performed a study to evaluate the common genotyping prescriptions referred to the CNRGS over the last three years. Results: Between February2006 and February2009, the CNRGS performed 2392 genotyping, including 981 common genotyping. Analysis of 172 common genotyping performed in 2008 showed that 63.8% of the prescriptions expressed a genotyping demand. Of the latter, 42.7% were genotyping prescriptions only, whereas 57.2% were prescriptions of genotyping associated with alloantibody identification. All prescriptions refer to blood group genotyping indications issued from guidelines, with no incorrect prescription, that are patients transfused within four months before blood sampling in 63.6% of cases or a positive direct antiglobulin test in 24.5% of cases. Lastly, 36% of the blood samples referred to the CNRGS had no genotyping prescription. Yet, common genotyping was performed by the CNRGS to get complete immunohematology data for antibody identification. Conclusion: Usefulness of blood group genotyping in specialized immunohematology laboratories is obvious. However, the strategy for implementation of molecular methods remains to be defined. Use of high-throughput DNA analysis should change our way of working. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
5. Donors with a rare pheno (geno) type.
- Author
-
Reesink, H. W., Engelfriet, C. P., Schennach, H., Gassner, C., Wendel, S., Fontão-Wendel, R., de Brito, M. A., Sistonen, P., Matilainen, J., Peyrard, T., Pham, B. N., Rouger, P., Le Pennec, P. Y., Flegel, W. A., von Zabern, I., Lin, C. K., Tsoi, W. C., Hoffer, I., Barotine-Toth, K., and Joshi, S. R.
- Subjects
- *
BLOOD cells , *ERYTHROCYTES , *PATIENTS , *ANTIGENS , *BLOOD donors - Abstract
The article presents questions and answers related to red blood cells for patients who are negative for a high-frequency antigen including the definition of a rare donor, problems encountered in finding compatible red blood cells (RBC) for patients, and whether countries have a national panel of rare donors and/or a national bank of frozen (RBC) units from such donors.
- Published
- 2008
- Full Text
- View/download PDF
6. Section 1B: Rh flow cytometryCoordinatorˈs report.Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination
- Author
-
Flegel, W.A., Čurin-Šerbec, V., Delamaire, M., Donvito, B., Ikeda, H., Jørgensen, J., Kumpel, B., Le Pennec, P.-Y., Písačka, M., Tani, Y., Uchikawa, M., Wendel, S., and Wagner, F.F.
- Subjects
- *
MONOCLONAL antibodies , *IMMUNOGLOBULIN G , *FLOW cytometry - Abstract
Fifty-seven IgG monoclonal anti-D antibodies were evaluated in the Rh flow cytometry section, in which 12 laboratories participated. Staining protocols and a fluorescein (FITC)-conjugated Fab fragment goat anti-human IgG (H+ L) as a secondary antibody were recommended but not mandatory. A CcDEe red blood cell (RBC) sample that was shown to be homozygous for RHD by molecular methods was supplied and used as internal ‘standard RBC’ throughout all experiments. An RBC panel comprising two partial D and four weak D types was supplied as well. The use of standard RBC reduced the variability of the data among the laboratories and allowed the conversion of fluorescence data into epitope densities, which were compounded in an antigen density (antigen D per RBC). The highest antigen density was determined for DVI type III, followed by DVII and weak D type 3; the lowest antigen density were determined for weak D type 1 and type 2. Nine of the 12 participating laboratories discriminated three groups of aberrant RhD that had similar Rhesus indices (RI): D category VI with RI = 0; weak D type 2 and type 3 with an high RI; and D category VII and weak D type 1 with an intermediate RI. The antigen densities and the Rhesus indices obtained correlated well among the laboratories of this Workshop section despite different staining protocols, secondary antibodies and instrumentation. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
7. Blood group genotyping by high-throughput DNA analysis: Application to the French panel of RBC reagents
- Author
-
Kappler-Gratias, S., Peyrard, T., Rouger, P., Le Pennec, P.-Y., and Pham, B.-N.
- Subjects
- *
BLOOD group antigens , *PHENOTYPES , *DNA , *BLOOD transfusion , *GENOTYPE-environment interaction , *ERYTHROCYTES , *BLOOD donors - Abstract
Abstract: Background: The use of blood group genotyping for the prediction of antigen expression has been discussed in clinical transfusion settings, but much less for reagent red blood cells selection. In France, the Centre National de Référence pour les Groupes Sanguins (CNRGS) produces a reference panel of reagent red blood cells, mainly used for red cell antibody identification. The use of high-throughput DNA analysis has never been applied to blood donors whose red blood cells are used as reagents. The aim of this study was to compare the serological phenotype and that predicted from DNA analysis in such donors, and to determine the benefit of DNA analysis in reagent red blood cells selection strategy. Study design and method: Red blood cells of 346 blood donors were typed with two different reagents for each antigen. The genotyping was performed by using HEA v1.2 BeadChips, BioArray Solutions, Immucor. The comparison between the serologically determined phenotype and that predicted from DNA analysis held on 8876 paired results obtained from 10 blood group systems and 25 antigens. Results: A 99.95% concordance was observed. Four cases of discrepancy for RH, KEL, LU and DO blood group systems were analyzed. Genotyping precisions were of special interest for the Duffy blood group system. Conclusion: Systematic DNA analysis brings important information on reagent red blood cells selection. It can be used at a routine level. Especially, the notion of “antigen of double dose” which is specified in several countries by government bodies should evolve regarding data obtained from DNA analysis. This should improve the quality of reagent red blood cells as first step for antibody identification. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.